Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00766571 · ClinicalTrials.gov registry record
Clinical and Genetic Studies of VACTERL Association
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 304
- Enrollment target
NCT00766571: Completed study, sponsored by National Human Genome Research Institute (NHGRI).
NCT00766571 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 304 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00766571 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 304 participants
- Enrollment target
Study Summary
This study will explore the medical problems in patients with VACTERL association and identify gene changes that might be responsible for them. VACTERL association can affect many parts of the body, including the bones of the spine, the heart, the lower intestinal tract, the connection between the trachea and esophagus, the kidneys and the arms. Information from this study may lead to a better understanding of the disease and improved treatment and genetic counseling. Patients with VACTERL association and their parents and siblings may be eligible for this study. Patients are admitted to the NIH Clinical Center for evaluation over 3 to 4 days that may include the following procedures: * Physical examination, medical history, electrocardiogram (EKG), blood and urine tests * Eye examination * Imaging studies (echocardiogram, x-rays and ultrasound tests) * Other specialized tests or consultations as indicated * Optional medical photographs of the face and other body parts that may be involved in VACTERL association for publication in scientific texts or for teaching purposes * Optional return visit after 2 years for repeat testing and to look for changes over time Parents of patients have the following procedures: * Physical examination, medical history, blood tests and x-rays, if needed * Specialty consultations as indicated * Optional medical photographs of the face and other body parts that may be involved in VACTERL association for publication in scientific texts or for teaching purposes * Questionnaires about their child s medical history, growth, behavior and development, therapy and medication Siblings of patients have the following procedures: * Physical examination, medical history and blood tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2008-09-29 |
| Est. Completion | 2017-06-29 |
What the finished NCT00766571 record still lists
NCT00766571 is an observational study that tracks outcomes without assigning an intervention. The registered 304 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00766571 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00766571 about?
NCT00766571 is a clinical study titled "Clinical and Genetic Studies of VACTERL Association". This study will explore the medical problems in patients with VACTERL association and identify gene changes that might be responsible for them. VACTERL association can affect many parts of the body, including the bones of the spine, the heart, the lower intestinal tract, the connection between the t...
What is the current status of trial NCT00766571?
This trial is currently completed. The enrollment target is 304 participants. The study started on 2008-09-29. Estimated completion is 2017-06-29.
Who is sponsoring clinical trial NCT00766571?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
- NCT06096844 · 304 participants · Phase 3
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI